Finance

Organogenesis

$10.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.71 (-6.49%) As of 3:59 PM UTC today

Why Robinhood?

You can buy or sell Organogenesis and other stocks, options, and ETFs commission-free!

About ORGO

Organogenesis Holdings Inc. Class A Common Stock, also called Organogenesis, is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA. The listed name for ORGO is Organogenesis Holdings Inc. Class A Common Stock.

CEO
Gary S. Gillheeney
Employees
835
Headquarters
Canton, Massachusetts
Founded
1985
Market Cap
1.28B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.28M
High Today
$11.05
Low Today
$9.91
Open Price
$11.02
Volume
407.45K
52 Week High
$11.13
52 Week Low
$2.47

Collections

ORGO Earnings

-$0.22
-$0.08
$0.05
$0.19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 8, After Hours

You May Also Like

GSS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure